机构名称：
¥ 1.0
• Fadi Issa (Oxford): Treg Cell Therapy Approach • Georg Böhmig (Vienna): Targeting CD38 in Antibody-Mediated Rejection • Lionel Rostaing (Grenoble): Desensitization Strategies: Tools and Results • Rolf Weimer (Giessen): Is Rituximab Useful or Harmful in ABOi Tx?
CTS - Tirex专家会议
主要关键词
相关文件推荐
